Dendritic Cell‐Specific Transmembrane Protein (DC‐STAMP) Regulates Osteoclast Differentiation via the Ca2+/NFATc1 Axis
Authors:
- Ya‐Hui ChiuYCYa‐Hui Chiu
- Edward SchwarzEdward Schwarz
- Dongge LiDLDongge Li
- Yuexin XuYXYuexin Xu
- Tzong‐Ren SheuTSTzong‐Ren Sheu
- Jinbo LiJLJinbo Li
- Karen L. de Mesy BentleyKBKaren L. de Mesy Bentley
- Changyong FengCFChangyong Feng
- Baoli WangBWBaoli Wang
- Jhih‐Cheng WangJWJhih‐Cheng Wang
- Liz Albertorio‐SaezLALiz Albertorio‐Saez
- Ronald WoodRWRonald Wood
- 10 October 2016
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 232 (9) , 2538-2549
Abstract
DC‐STAMP is a multi‐pass transmembrane protein essential for cell–cell fusion between osteoclast precursors during osteoclast (OC) development. DC‐STAMP−/− mice have mild osteopetrosis and form mononuclear cells with limited resorption capacity. The identification of an Immunoreceptor Tyrosine‐based Inhibitory Motif (ITIM) on the cytoplasmic tail of DC‐STAMP suggested a potential signaling function. The absence of a known DC‐STAMP ligand, however, has hindered the elucidation of downstream signaling pathways. To address this problem, we engineered a light‐activatable DC‐STAMP chimeric molecule in which light exposure mimics ligand engagement that can be traced by downstream Ca2+ signaling. Deletion of the cytoplasmic ITIM resulted in a significant elevation in the amplitude and duration of intracellular Ca2+ flux. Decreased NFATc1 expression in DC‐STAMP−/− cells was restored by DC‐STAMP over‐expression. Multiple biological phenotypes including cell–cell fusion, bone erosion, cell mobility, DC‐STAMP cell surface distribution, and NFATc1 nuclear translocation were altered by deletion of the ITIM and adjacent amino acids. In contrast, mutations on each of the tyrosine residues surrounding the ITIM showed no effect on DC‐STAMP function. Collectively, our results suggest that the ITIM on DC‐STAMP is a functional motif that regulates osteoclast differentiation through the NFATc1/Ca2+ axis. J. Cell. Physiol. 232: 2538–2549, 2017.Keywords
Funding Information
- National Institutes of Health (AR0169000, 5UL1TR000042-09, P30AR069655)
This publication has 47 references indexed in Scilit:
- MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiationBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2014
- RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesisJournal of Clinical Investigation, 2014
- RETRACTED ARTICLE: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2Nature, 2014
- Pin1 Regulates Osteoclast Fusion Through Suppression of the Master Regulator of Cell Fusion DC‐STAMPJournal of Cellular Physiology, 2014
- Osteoclast Fusion is Based on Heterogeneity Between Fusion PartnersCalcified Tissue International, 2014
- Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP)Journal of Bone and Mineral Research, 2011
- CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritisArthritis Research & Therapy, 2010
- Nuclear Factor of Activated T-cells (NFAT) Rescues Osteoclastogenesis in Precursors Lacking c-FosJournal of Biological Chemistry, 2004
- Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of OsteoclastsDevelopmental Cell, 2002
- DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cellsEuropean Journal of Immunology, 2000